Fig. 1From: Circulating osteocalcin is associated with time in range and other metrics assessed by continuous glucose monitoring in type 2 diabetesTIR of each group by quartile of osteocalcin levels (G1:osteocalcin < 10.68 ng/ml, G2:10.68 ng/ml≦osteocalcin < 13.72 ng/ml, G3:13.72 ng/ml≦osteocalcin < 17.30 ng/ml, G4:osteocalcin≧17.30 ng/ml). Kruskal–Wallis H test was applied to show statistical significance of comparison between groups (n = 94 per group) *p = 0.001Back to article page